We evaluated the inhibitory effects of components from the root of Glycyrrhiza uralensis (G. uralensis) on aldose reductase (AR) and sorbitol formation in rat lenses with high levels of glucose as part of our ongoing search of natural sources for therapeutic and preventive agents for diabetic complications. In order to identify the bioactive components of G. uralensis, 5 prenylated flavonoids (semilicoisoflavone B, 7-O-methylluteone, dehydroglyasperin C, dehydroglyasperin D, and isoangustone A), three flavonoids (liquiritigenin, isoliquiritigenin, and licochalcone A), and two triterpenoids (glycyrrhizin and glycyrrhetinic acid) were isolated; their chemical structures were then elucidated on the basis of spectroscopic evidence and comparison with published data. The anti-diabetic complication activities of 10 G. uralensis-derived components were investigated via inhibitory assays using rat lens AR (rAR) and human recombinant AR (rhAR). From the 10 isolated compounds, semilicoisoflavone B showed the most potent inhibition, with the IC 50 values of rAR and rhAR at 1.8 and 10.6 m mM, respectively. In the kinetic analyses using Lineweaver-Burk plots of 1/velocity and 1/concentration of substrate, semilicoisoflavone B showed noncompetitive inhibition against rhAR. The results clearly indicated that the presence of a g g,g g-dimethylchromene ring is partly responsible for the AR inhibitory activity of isoprenoid-type flavonoids. Further, semilicoisoflavone B inhibited sorbitol formation of rat lens incubated with a high concentration of glucose, indicating that this compound may be effective for preventing osmotic stress in hyperglycemia.
Diabetic complications are characterized by the accumulation of sorbitol. The formation of sorbitol is mediated by aldose reductase (AR), which catalyzes the nicotinamide adenine dinucleotide phosphate (NADPH)-dependent reduction of various aldehyde such as glucose and galactose to their corresponding sugar alcohols. Sorbitol can be produced more rapidly by AR than it is converted to fructose by sorbitol dehydrogenase, resulting in an accumulation of sorbitol. 1, 2) An important factor in the pathogenesis of diabetic complications is the excessive accumulation of intracellular sorbitol found in the tissues of diabetic animals and in cells cultured under high glucose conditions. 3, 4) This sugar alcohol can produce a hyperosmotic effect, which has been observed to lead to membrane permeability changes and the onset of cellular pathology. 5) Although the development and progression of diabetic complications can be prevented by controlling blood glucose, it is difficult to regulate normal blood glucose in a diabetic patient. Therefore, AR inhibition has been recognized as an important strategy in the prevention and attenuation of long-term diabetic complications; further, AR inhibitors are being studied as potential therapeutics against diabetic complications.
6,7)
The roots and rhizomes of licorice species (Glycyrrhiza sp.) have for long been used, worldwide, as an herbal medicine and natural sweetener. Licorice root is considered to be a traditional medicine used mainly for the treatment of peptic ulcers, hepatitis C, and pulmonary and skin diseases. 8) Clinical and experimental studies suggest that licorice root has several other useful pharmacological properties such as antiulcer, anti-inflammatory, antimicrobial, antioxidant, anticancer, anti-tyrosinase activities. [9] [10] [11] [12] [13] A large number of components have been isolated from licorice, including triterpenes saponins, flavonoids, isoflavonoids, and chalcones; glycyrrhizic acid is normally considered to be the main biologically active component. 14) However, there are few reports of the potential activity of licorice-derived compounds against diabetes or diabetes-related complications. 18b-Glycyrrhetinic acid, a glycyrrhizin aglycone, has been reported to improve glucose tolerance more effectively than glycyrrhizin by enhancing insulinotropic action. 15) Another licorice flavonoid-isoliquiritigenin-exhibited potent inhibitory activity against rat lens AR and suppressed sorbitol accumulation in the red blood cells, the sciatic nerve, and the lens in the diabetic rat. 16) Several studies have suggested that licorice can improve glucose tolerance in diabetic mice, partly through the activation of the peroxisome proliferation activated receptor (PPAR-g) pathway and through the activity of prenylflavonoids such as glycycoumarin, glycyrin, and dehydroglyasperin C and D. 17, 18) The preventive and inhibitory activities against diabetes, shown by several licorice-derived components, points to the importance of further investigation into the inhibitory effects of Glycyrrhiza uralensis on diabetic complications. Therefore, the objective of the present study is to evaluate inhibitory effects of G. uralensis-derived compounds on AR and sorbitol formation in rat lens.
MATERIALS AND METHODS

Chemicals
1 H-and 13 C-NMR spectra were recorded with a Bruker Avance 600 NMR NMR spectrometer (Karlsrube, Germany) operating at 600 and 150 MHz, respectively. DL-Glyceraldehyde, the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH), quercetin, TL-100 medium, and antibiotics from Sigma (St. Louis, MO, U.S.A.) and recombinant human AR from Wako Pure Chemical Industries (Osaka, Japan) were purchased. Fetal bovine serum was from GenDEPOT (U.S.A.). Epalrestat (ONO-2235) was obtained from Ono Pharmaceutical Co., Ltd. (Osaka, Japan).
Plant Materials Plant material "Licorice" used in this study was purchased from a local market in Chuncheon. The voucher sample (RIC-HU1204) has been deposited at the center for efficacy assessment and development of functional foods and drugs, Hallym University, Chuncheon. The specimens were authenticated by Emeritus Prof. H.J. Chi, Seoul National University, Korea.
Extraction and Isolation Dried rhizomes of G. uralensis (3 kg) were extracted with methylene chloride (MC, 20 lϫ 3 times) overnight at room temperature. The total filtrate was concentrated to dryness in vacuo at 40°C to render the MC extract (120 g, 4%). A portion of the extract (80 g) was chromatographed over a Si gel column (70 to 230 mesh; Merck Co., 110ϫ1000 mm), using n-hexane : EtOAc (3 : 1 to 1 : 4, gradient) as the solvent to obtain 13 fractions (Fr. 1 to Fr. 13). Of these, Frs. 5 and 9 showed the most potent rAR inhibitory activity. Fraction 5 was subjected to column chromatography over RP-18 gel (LiChroprep RP-18, 40-63 mm, Merck, Darmstadt, Germany) with 53% MeOH to yield semilicoisoflavone B (1, 15 mg) and 7-O-methylluteone (2, 11 mg). Fraction 9 (5.0 g) was subjected to RP-18 column chromatography (50 to 100% MeOH, gradient), yielding dehydroglyasperin C (3, 30 mg), dehydroglyasperin D (4, 36 mg), isoangustone A (5, 158 mg), liquiritigenin (6, 11.6 mg), and isoliquiritigenin (7, 8 mg) . By the above method, licochalcone A (8, 15 mg), glycyrrhizin (9, 5 mg), and glycyrrhetinic acid (10, 8 mg) from Fr. 11 were also obtained.
Assay for Rat Lens Aldose Reductase Inhibitory Activity Crude aldose reductase was prepared as follows: Rat lenses were removed from closed male Sprague-Dawley rats weighing 250-280 g and frozen until required. The rat lens homogenate was prepared according to the method of Hayman and Kinoshita with some modifications. [19] [20] [21] A partially purified enzyme with a specific activity of 6.5 U/mg was routinely used to test the enzyme inhibition. The partially purified material was separated into 1.0 ml aliquots and stored at 40°C. Rat lens aldose reductase (rAR) activity was assayed spectrophotometrically by measuring the decrease in the absorption of NADPH at 340 nm over a 4-min period with DL-glyceraldehyde as the substrate. Each 1.0 ml cuvette contained equal units of the enzyme, 0.10 M sodium phosphate buffer (pH 6.2), 0.3 mM NADPH, with or without 10 mM of the substrate and an inhibitor. 22, 23) The concentration of inhibitors giving 50% inhibition of enzyme activity (IC 50 ) was calculated from the least-squares regression line of the logarithmic concentrations plotted against the residual activity.
Assay for Recombinant Human Aldose Reductase Inhibitory Activity Recombinant human aldose reductase (rhAR) activities were assayed spectrophotometrically by measuring the decrease in absorption of NADPH. 24) rhAR activity was carried out at 37°C in a 100 mM sodium phosphate buffer (pH 6.2) containing 10 mM DL-glyceraldehyde, 0.3 mM NADPH, and rhAR in a total volume of 1.0 ml. The reaction was initiated by adding the substrate and the rate of NADPH oxidation was monitored by recording the decrease in absorbance at 340 nm. The concentration of inhibitors giving IC 50 was calculated from the least-squares regression line of the logarithmic concentrations plotted against the residual activity.
Determination of Inhibition-Type of rhAR by Active Compound Reaction mixtures consisted of 0.1 M potassium phosphate (pH 7.0), 0.16 mM NADPH, 2 mM of rhAR with varied concentrations of substrate DL-glyceraldehyde and aldose reductase inhibitor in a total volume of 200 ml. Concentrations were ranged from 0.02 to 0.2 mM for DL-glyceraldehyde, from 0.1 to 0.5 mM for active compound. rhAR activity was assayed spectrophotometrically by measuring the decrease in absorption of NADPH at 340 nm after substrate addition using BioTek Power Wave XS spectrophotometer (BioTek Instruments, VT, U.S.A.).
Lens Culture and Intracellular Sorbitol Measurement Lenses isolated form 10-week-old male Wistar rats were cultured for 6 d in TC-199 medium that contained 15% fetal bovine serum 100 units/ml penicillin and 0.1 mg/ml streptomycin under sterile conditions in an atmosphere of 5% CO 2 and 95% air at 37°C. Samples were dissolved in dimethylsulfoxide. The lenses were divided into 3 groups and cultured in medium containing 25.5 mM glucose and semilicoisoflavone A or isoliquiritigenin. Each lens was placed in a well containing 2.0 ml of medium. Sorbitol was determined by HPLC after its derivatization by reaction with benzoic acid to a fluorescent compound. 25) RESULTS AND DISCUSSION The present study was carried out to obtain a new potential AR inhibitor-from the Glycyrrhiza species-that can be used in the treatment of diabetic complications. A methylene chloride extract from G. uralensis was found to exhibit inhibitory activity against rAR. Using bioactivity-guided separation of this extract, 10 compounds from the roots of G. uralensis were isolated and tested for their effects on rAR and rhAR. Their chemical structures were elucidated by spectral analysis and are shown in Fig. 1 .
As shown in Fig. 1 , compounds 1-5 are isoflavonoids, commonly possessing an isoprenoid group in their structures. However, compound 1 and compounds 2-5 differ in the form of their component isoprenoid group, with the former containing a g,g-dimethylchromene ring on the aromatic ring and the latter, a g,g-dimethylallyl group. The inhibitory activity of compounds 1-10 against rAR and rhAR was tested using quercetin-a known AR inhibitor-as a positive control. Of the tested compounds, semilicoisoflavone B (1) containing a g,g-dimethylchromene ring on the aromatic ring exhibited the most potent inhibitory activity with an IC 50 value of 1.8 mM for rAR and 10.6 mM for rhAR. Further, liquiritigenin (6) and isoliquiritigenin (7), prenyl free flavonoids, were potent inhibitors of rAR, with IC 50 values of 2.0 and 3.4 mM, respectively, compared to quercetin, which had an IC 50 of 2.5 mM. They were also found to inhibit rhAR, with IC 50 values 21.9 and 27.5 mM, respectively (Table 1 ). In contrast, compounds 2-5, a g,g-dimethylallyl type prenylated isoflavonoids, showed weak inhibitory activity against rAR and rhAR. Their IC 50 values were in the range of 28.5 to 99.5 mM for rAR and 76.5 to 280.8 mM for rhAR. Finally, inhibition is greater in g,g-dimethylchromene ring than g,g-dimethylallyl group on the aromatic ring, the rigidity of the side chain has beneficial effects.
However, compounds 9-10 did not exhibit any inhibitory activity. Generally, active compounds showed 3-10 times stronger inhibitory activity against rAR than that of rhAR. Various aldose reductase inhibitors are known to show different effectiveness among animal species, indicating that a minor dissimilarity in the protein structure and the inhibitorbinding site may be concerned with the different activity of inhibitors. 26) Flavonoids are reported to be effective inhibitors of lens aldose reductase. Especially, it has been established that quercetin, quercitrin, and myricitrin are more potent than alrestatin (AY-22284), the lead compound which preceded tolrestat. Also, the type of inhibition by these flavonoids is noncompetitive, a factor preferable in therapeutic use over competitive inhibitors. 27, 28) Furthermore, previous studies indicate that common feature of aldose reductase inhibitors is a hydrophobic region attached to an acid group. The flavonoids meet these requirements. Also, there are many reports that quercetin as a positive control has been used to compare to inhibitory activity of active compounds isolated from natural products against lens or human recombinant aldose reductase. [29] [30] [31] [32] [33] Since the form of the isoprenoid group can affect the inhibitory activity against AR, we sought to determine the type of inhibition of compound 1 with a kinetic study using DLglyceraldehyde as a substrate at a concentration of 0.2-2 mM. A kinetic analysis of AR inhibition by semilicoisoflavone B (1) using Lineweaver-Burk plots of 1/velocity and 1/concentration of substrate is shown in Fig. 2 . When the concentration of the substrate DL-glyceraldehyde was changed, the slopes obtained from the uninhibited enzyme and three different concentrations of semilicoisoflavone B were found to be parallel. The results show that the inhibition of rhAR by semilicoisoflavone B was uncompetitive, meaning that the inhibitor was unable to bind to either the substrate binding region or the NADPH binding region of rhAR. Liquiritigenin (6) and isoliquiritigenin (7) were also evaluated to determine the type of inhibition with respect to DLglyceraldehyde. As shown in Fig. 2 , these two compounds also showed uncompetitive inhibition pattern against rhAR.
To confirm the effectiveness of compounds 1, 6, and 7 ex vivo, we also studied the effects of these compounds on sorbitol accumulation in rat lens. Under hyperglycemic condition, sorbitol can be produced more rapidly than it is converted to fructose, resulting in an accumulation of sorbitol. The intracellular accumulation is enhanced by the polar nature of the sugar alcohol, since its polarity prevents facile membrane penetration and subsequent removal through diffusion. The intracellular accumulation of a polar sugar alcohol can thus produce an hyperosmotic effect, which results in an infusion of fluid to counteract the osmotic gradient produced. The fluid influx has been observed to lead to membrane permeability changes and the onset of cellular pathology. 34) Incubated rat lens for 6 d in 25.5 mM glucose has resulted in the increased intracellular accumulation of sorbitol. As shown in Table 2 , semilicoisoflavone B (1) and isoliquiritigenin (7) inhibited sorbitol accumulation by 46.8 and 46.0% at 1 mM, respectively. On the other hand, liquiritigenin (6) had no effect. Also, quercetin as a positive control, which inhibits sorbitol accumulation in isolated rat lenses by 59.68%, in the culture medium containing a high glucose concentration significantly reduced the sorbitol level.
In the present study, semilicoisoflavone B, a prenylated isoflavone with g,g-dimethylchromene moiety, from G. uralensis exhibited strong rAR and rhAR inhibitory activities, and it can be said to be potential lead compounds for further development as natural drugs for diabetic complications. Vol. 33, No. 5 
